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Background: Few efficacious early treatments for post-traumatic stress disorder (PTSD) in children and adolescents
exist. Previous trials have intervened within the first month post-trauma and focused on secondary prevention of
later post-traumatic stress; however, considerable natural recovery may still occur up to 6-months post-trauma. No
trials have addressed the early treatment of established PTSD (i.e. 2- to 6-months post-trauma). Methods: Twenty-
nine youth (8–17 years) with PTSD (according to age-appropriate DSM-IV or ICD-10 diagnostic criteria) after a single-
event trauma in the previous 2–6 months were randomly allocated to Cognitive Therapy for PTSD (CT-PTSD; n = 14)
or waiting list (WL; n = 15) for 10 weeks. Results: Significantly more participants were free of PTSD after CT-PTSD
(71%) than WL (27%) at posttreatment (intent-to-treat, 95% CI for difference .04–.71). CT-PTSD yielded greater
improvement on child-report questionnaire measures of PTSD, depression and anxiety; clinician-rated functioning;
and parent-reported outcomes. Recovery after CT-PTSD was maintained at 6- and 12-month posttreatment.
Beneficial effects of CT-PTSD were mediated through changes in appraisals and safety-seeking behaviours, as
predicted by cognitive models of PTSD. CT-PTSD was considered acceptable on the basis of low dropout and high
treatment credibility and therapist alliance ratings. Conclusions: This trial provides preliminary support for the
efficacy and acceptability of CT-PTSD as an early treatment for PTSD in youth. Moreover, the trial did not support the
extension of ‘watchful waiting’ into the 2- to 6-month post-trauma window, as significant improvements in the WL
arm (particularly in terms of functioning and depression) were not observed. Replication in larger samples is needed,
but attention to recruitment issues will be required. Keywords: Post-traumatic stress disorder; cognitive therapy.
Introduction
Trauma exposure in childhood and adolescence is
common, with post-traumatic stress disorder (PTSD)
occurring in a significant minority (15.9% in a recent
meta-analysis; Alisic et al., 2014). PTSD can take a
chronic course in this age group (Yule et al., 2000)
and impact significantly on academic and social
functioning and mental health in adulthood. Numer-
ous efforts have been made to intervene within the
first month post-trauma to prevent the development
of PTSD to single-event traumas in youth. These have
focused on youth attending hospital emergency
departments (EDs) andcomprised verybrief universal
interventions (i.e. 1–2 sessions), typically debriefing
or psychoeducation, delivered to all trauma-exposed
young people within a month of the trauma. As
in adults, these universal approaches demonstrate
little or no improvement over no intervention/natural
recovery (Marsac, Donlon, & Berkowitz, 2014).
An alternative approach is to intervene early only
with those who show initial PTSD symptoms or
present with PTSD. Information provision in the first
2 weeks post-trauma may reduce PTSD symptoms
in youth with marked traumatic stress (Kenardy,
Cox, & Brown, 2015). In the only meta-analysis to
consider interventions in the first month post-trauma
in youth (Kramer & Landolt, 2011), only one study
was found to be efficacious: Berkowitz, Stover, and
Marans (2011) evaluated a multi-session early inter-
vention in youth recently exposed to a trauma, who
presented with at least one new PTSD symptom.
Their four-session, cognitive-behavioural treatment
package aimed at improving caregiver-child commu-
nication and trauma-related coping reduced the
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likelihood of developing PTSD relative to supportive
counselling. Although limited by potential bias (non-
blind assessments), inclusion of youth where symp-
toms may have stemmed from multiple traumas
(making onset unclear) and lack of control for the
effects of natural recovery, this study suggests that
an early, targeted psychological treatment for youth
at risk of PTSD is feasible and likely efficacious.
To date, no studies have evaluated treating trauma-
exposed youthwith either PTSD or symptoms of PTSD
in the early (i.e. 2- to 6-months post-trauma), but not
acute (i.e. within a months post-trauma) period. This
early treatment window is important for several rea-
sons. First, it is not knownwhether treatment in the 2-
to 6-months period would have any advantage over
natural recovery. One group has found that most
recovery occurs by 2–3 months (Le Brocque, Hen-
drikz, & Kenardy, 2010). However, a recent meta-
analysis suggest that considerable natural recovery
can occur up to 6-months post-trauma (Hiller et al.,
2016). Establishing that any active intervention is
superior to ‘watchful waiting’ (i.e. a period without
intervention where an individual is ‘either encouraged
to return for further assessment or offered a specific
appointment time’, p18; National Institute for Clinical
Excellence, 2005) is an essential first step for the
future refinement of early treatment approaches.
Second, children and adolescents typically face great
barriers in accessing care (e.g. being frequently reliant
on parents to refer them to services, a lack of aware-
ness among children themselves that traumatic stress
is a recognized mental health difficulty), making
treatment in the first month rare in routine settings.
Third, PTSD cannot be diagnosed within 4 weeks of a
trauma as diagnostic systems recognize that some
acute traumatic stress is normal and may recede
without intervention. Fourth, adult studies show that
treatment may be successful in this early window (i.e.
after the first month, but within 6-months post-
trauma; Ehlers et al., 2003); we, therefore, sought to
replicate that finding in children and young people.
In the light of the current lack of data concerning
efficacious, brief universal interventions for trauma-
exposed youth, new models for managing early
traumatic stress reactions have been proposed.
These have included contexts such as large-scale
disasters (McDermott & Cobham, 2014) and acci-
dental injuries seen in emergency departments
(Cobham et al., 2012; Kassam-Adams, 2014).
Stepped-care approaches have, in particular, shown
to be efficacious in young children (Salloum et al.,
2016). There is also a need for indicated interven-
tions, where treatment is directed towards youth
considered to be at high risk of chronic difficulties
(Marsac et al., 2014). It is suggested that a study of a
multiple-session intervention for children and ado-
lescents with PTSD in the window described above is
an important step in the evolution of the early
management of traumatic stress in youth and would
support these other efforts. Treatment development
would be further accelerated by the examination of
mechanisms of action. This study was, therefore, a
randomized controlled trial (RCT) that addressed as
its primary aim whether Cognitive Therapy for PTSD
(CT-PTSD) is an efficacious early treatment in
trauma-exposed children and adolescents, delivered
2- to 6-months post-trauma. A CT-PTSD treatment
package tailored for children and adolescents was
employed (Smith, Perrin, Yule, & Clark, 2010). CT-
PTSD aims to reverse or ameliorate those mecha-
nisms proposed to maintain PTSD (trauma-related
misappraisals, characteristics of trauma memories,
and maladaptive behavioural and cognitive coping
strategies; Ehlers & Clark, 2000). This therapy was
selected because of its efficacy with youth exposed to
single-event trauma who developed chronic PTSD
(Smith et al., 2007), its success as an early treat-
ment for PTSD in adults (Ehlers et al., 2003; from
which the youth-focused CT-PTSD package was
adapted) and its focus on targeting mechanisms
found to be involved in the maintenance of PTSD in
youth (e.g. Palosaari, Punamaki, Diab, & Qouta,
2013). The control arm in this trial was a waiting list
(WL) as (a) there is an absence of any established
evidence-based practice for early treatment with
trauma-exposed youth; and (b) there is a critical
need to establish that treatment outperforms natural
recovery (a question not addressed by previous
trials). Pragmatically, WL also reflects ‘treatment as
usual’ for recently exposed youth with PTSD within
UK youth mental health services (as treatment would
not routinely be offered so soon post-trauma).
The secondary aim of the trial was to evaluate
whether CT-PTSD led to improvements in comorbid
disorders, functioning and parent-report psy-
chopathology. An exploratory aim was to evaluate
whether CT-PTSD exerts its effects through its
proposed mechanisms, i.e. whether effect of treat-
ment was mediated by changes in cognitive mecha-
nisms (as predicted by cognitive models) and/or
other more general but plausible psychosocial fac-
tors (thereby controlling for possible response bias).
In summary, it was hypothesized that: (a) CT-PTSD
would be superior to WL at posttreatment in terms of
PTSD diagnosis (our primary outcome); (b) CT-PTSD
would be superior to WL in terms of self-reported
post-traumatic stress, depression, and anxiety, clin-
ician-rated functioning and parent-reported mental
health and behavioural difficulties (our secondary
outcomes); and (c) any superiority of CT-PTSD over
WL would be mediated through changes in trauma-
related appraisals, trauma memory characteristics,
rumination and safety-seeking behaviours.
Method
Study design
An RCT approved by the UK National Research Ethics Service,
Cambridgeshire 1 Research Ethics Committee (10/H0304/11)
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and registered with the ISRCTN Registry (ISRCTN38352118).
Study protocol available from the first author.
Participants
Participants were recruited from sources across the East of
England (covering a broad socioeconomic range, including
urban and rural settings), including community mental health
teams, family doctors, schools, adverts in health clinics, and
emergency departments. Inclusion criteria were (a) 8–17 years
old; (b) main presenting problem of PTSD (using an age-
appropriate diagnostic algorithm) relating to a single trauma in
previous 2–6 months; and (c) fluency in English. Age-appro-
priate diagnoses are commonly used in treatment trials for
PTSD in youth (Cohen, Deblinger, Mannarino, & Steer, 2004).
Consequently, PTSD was defined, in accordance with evidence-
based practice for 8–18 year olds (Meiser-Stedman, Smith,
Glucksman, Yule, & Dalgleish, 2008; Scheeringa, Wright,
Hunt, & Zeanah, 2006), as the presence of one re-experiencing
symptom, one avoidance symptom, two hyperarousal symp-
toms and impaired functioning. This alternative algorithm
(PTSD-AA) avoided the excessively strict DSM-IV requirement
for three avoidance symptoms that would have applied at the
time the trial commenced (since altered for the DSM-5) but was
consistent with the ICD-10 PTSD diagnosis that was current at
the time of trial commencement. As such, all young people in
the trial met ICD-10 PTSD criteria. Pretreatment assessments
were conducted by two clinical psychologists (AM and RMS)
with extensive experience of assessing trauma-exposed youth.
In addition to confirming the presence or absence of PTSD,
these assessments were used to confirm that PTSD was
triggered by the recent index event, and not any prior trauma.
Exclusion criteria were as follows: (a) organic brain damage;
(b) unconscious >15 min during the trauma; (c) intellectual
disability or autistic spectrum disorder; (d) ongoing threat; (e)
recently initiated (within 3 months) psychotropic medication;
(f) receiving another psychological treatment; (g) acute treat-
ment required for suicide risk or other major mental health
problem.
Procedure
Randomization. Participants were randomized to CT-
PTSD or WL. A minimization procedure with stratification
according to age (<14 vs. ≥ 14 years), gender, symptom severity
(<28 vs. ≥ 28, derived from previous trial; Smith et al., 2007) on
the Child PTSD Symptom Scale (CPSS; Foa, Johnson, Feeny, &
Treadwell, 2001; Cronbach’s a = .89) and pretreatment diag-
nosis (i.e. meeting both DSM-IV and PTSD-AA criteria vs.
PTSD-AA criteria) was used to ensure each trial arm was
suitably matched on variables that might moderate outcome.
Assessments. Participants were assessed before random-
ization (‘pretreatment’), 5 weeks postrandomization (‘midtreat-
ment’), 11 weeks postrandomization (‘posttreatment’), and for
CT-PTSD, at 6- and 12-month post-end-of-treatment follow-up
assessments (‘6MFU’ and ‘12MFU’) to see if any treatment
gains persisted over time. WL cases were offered CT-PTSD at
the end of the wait period if clinically appropriate and did not,
therefore, take part in 6MFU and 12MFU.
Posttreatment interview assessments were administered by
postdoctoral- and postgraduate-level psychologists blind to
condition; assessors did not deliver treatment or contribute to
other elements of the trial and did not work in any of the
settings where CT-PTSD was delivered. Participants were
instructed not to disclose their treatment status to the asses-
sor. Blind raters were asked to guess allocation at the end of
the interview. For cases where blind raters made a guess
(n = 23), the agreement with actual allocation was no better
than chance (Cohen’s j = 09, p = .65); this suggests raters
were indeed blind. Assessments at 6MFU and 12MFU were not
blind as these were only administered to CT-PTSD partici-
pants.
Cognitive Therapy for PTSD (CT-PTSD). CT-PTSD
was based on a treatment approach (Ehlers et al., 2003)
derived from a cognitive model of PTSD (Ehlers & Clark, 2000),
with suitable adaptations for youth outlined in a published
treatment manual (Smith et al., 2010). Treatment was deliv-
ered via up to 10 weekly individual sessions, lasting up to
90 min each. Sessions typically involved the child alone, with
parents only joining the session to review what was covered
and help to plan homework tasks. Treatment components
included the following: psycho-education, activity scheduling/
reclaiming life, imaginal reliving, cognitive restructuring, re-
visiting the site of the trauma, stimulus discrimination with
respect to traumatic reminders, direct work with nightmares,
image transformation techniques and behavioural experi-
ments. CT-PTSD places particular emphasis on the close
integration of cognitive restructuring with reliving. The manual
includes guidance for tailoring treatment to a child’s
developmental needs (e.g. choice of clinical metaphors, age-
appropriate techniques for undertaking restructuring). The
current programme did not include relaxation training or other
arousal reduction techniques for treating PTSD symptoms.
Therapy sessions were discontinued when, after discussion
with the participant and review of session by session CPSS
scores, it was agreed that participants had no significant
further symptoms to address.
CT-PTSD was delivered by two clinical psychologists (RMS
and AM) who completed a 3-day training in CT-PTSD. Both of
these therapists had completed a clinical training that was
primarily cognitive behavioural in orientation and were no
more than 2 years postqualification at the start of the trial;
moreover, each had completed doctoral research projects that
concerned cognitive processes in childhood PTSD. Fortnightly
telephone supervision (by PS) addressed treatment adherence
as well as clinical issues and was supplemented by reviewing
clinical notes.
Measures
The Children’s PTSD Inventory (CPTSDI; Saigh et al., 2000), a
child-report structured interview, assessed the primary out-
come of PTSD-AA at pretreatment, posttreatment, 6MFU and
12MFU. The CPTSDI has excellent internal consistency, test–
retest reliability, and interrater reliability (Saigh et al., 2000).
The CPTSDI was also used to derive a continuous measure of
PTSD symptomatology (i.e. symptom count, range 0–17;
Cronbach’s a = .71 for this sample) and an ICD-10 diagnosis
of PTSD. Reliability of posttreatment PTSD-AA diagnoses was
examined using a subset of six randomly selected interviews by
a qualified clinical psychologist with extensive experience of
assessing trauma-exposed youth; complete agreement was
obtained.
The Anxiety Disorders Interview Schedule for the DSM–IV:
Child Version (ADIS-C; Silverman & Albano, 1996), a struc-
tured interview schedule that assesses for emotional and
behavioural disorders, was administered at pretreatment to
index comorbid diagnoses on the basis of parent and child
report (administered separately).
Several secondary outcomes were included. The Children’s
Global Assessment Scale (CGAS; Shaffer et al., 1983) pro-
vided a clinician-rated measurement of general functioning.
Youth-reported PTSD severity was assessed with the CPSS
(Cronbach’s a = .87 for this sample), depression with the
Mood and Feelings Questionnaire (MFQ; Cronbach’s a = .94,
Wood, Kroll, Moore, & Harrington, 1995; .94 for this
© 2016 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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sample), and anxiety was assessed with the Spence Child
Anxiety Scale (SCAS; Spence, 1998; Cronbach’s a = .92; .93
for this sample). Parents completed the Strengths and
Difficulties Questionnaire (SDQ; Goodman, 2001), an index
of child emotional difficulties, conduct and hyperactivity
(Cronbach’s a = .66, .60 and .67, respectively; .81, .63 and
.78 for this sample). Youth rated their therapist alliance
using the Therapeutic Alliance Scale for Children, revised
(TASC-r; Shirk & Saiz, 1992; subscale Cronbach’s
a = .67–.74; .74 for total scale in this sample). Youth-
reported treatment credibility was assessed using items
adapted from an adult PTSD trial (Ehlers et al., 2003;
Cronbach’s a = .86 for this sample). Intellectual ability was
assessed at pretreatment using two subtests of the Wechsler
Abbreviated Scale of Intelligence (Wechsler, 1999).
For mediation analyses, measures of cognitive mechanisms
proposed by cognitive models to underlie the maintenance of
PTSD were administered at pre-, mid- and posttreatment. The
cognitive mechanisms assessed were (a) trauma-related mis-
appraisals [Child Post-Traumatic Cognitions Inventory
(CPTCI); Meiser-Stedman et al., 2009; Cronbach’s a > .86;
.96 for this sample]; (b) trauma memory characteristics
[Trauma Memory Quality Questionnaire (TMQQ); Meiser-
Stedman, Smith, Yule, & Dalgleish, 2007; Cronbach’s
a > .76; .61 for this sample]; and (c) unhelpful coping strate-
gies including rumination (a three-item scale; Meiser-Stedman
et al., 2014; Cronbach’s a = .85; .64 for this sample) and
safety-seeking behaviours (a novel 22-item measure devised
for this trial; Cronbach’s a = .96). Measures of generic psy-
chosocial risk factors – social support [Multidimensional Scale
of Perceived Social Support (MSPSS); Zimet, Dahlem, Zimet, &
Farley, 1988; Cronbach’s a = .88; .92 for this sample] and self-
blame (a two-item scale devised for this study; Cronbach’s
a = .94) – were also administered.
Data analysis
Sample size was determined by power calculations based on an
estimated recovery rate (loss of diagnosis) of 92% for CT-PTSD
versus 42% for WL derived from our trial of CT-PTSD versus
WL for chronic PTSD (Smith et al., 2007). Assuming these
recovery rates, 13 children per group would provide 80% power
to detect a difference between CT-PTSD and WL with a = .05
(two-tailed).
An intent-to-treat (ITT) approach to the analysis of primary
and secondary outcomes was adopted, conducted by an
independent statistician, with analyses for completers (partic-
ipants who completed measures at posttreatment) also
reported. For categorical (diagnostic) outcome data, including
the primary outcome variable (child-reported PTSD-AA at
posttreatment), chi-square (or Fisher’s exact) tests were per-
formed. In order to account for missing diagnostic data, both
‘last observation carried forward’ (LOCF; assumes missing
cases retain their baseline diagnosis) and more conservative
‘worst case scenario’ (WCS; assumes that treatment arm cases
do not recover while waiting list cases do recover) procedures
are reported.
For ITT analyses with continuous outcomes, a multiple
imputation procedure was used to account for data lost
through drop out, the value of which we assume relates to
observed variables in the data. This procedure used a chained
equations multiple imputation procedure (Van Buuren, 2007)
and five imputations, conducted in SPSS 22.0 (IBM Corp.,
Armonk, NY, USA). We incorporated the pretreatment score
and allocation group in modelling. Pooled regression estimates
and their standard errors were computed across imputations
using Rubin’s rules (Rubin, 1987). ANCOVAs were carried out
on post-CT-PTSD/WL data to detect any between-groups
differences at posttreatment, accounting for pretreatment
symptom levels.
Between-groups (CT-PTSD vs. WL) and within-subjects (pre–
post) effect sizes are reported for primary and secondary
outcomemeasures. Within-subjects and between-groups effect
sizes were calculated on the basis of pooled standard devia-
tions (Cohen’s d). Following Jacobson, Follette, and Revenstorf
(1984), clinically significant change was considered to have
occurred when a participant’s posttreatment CPSS score was
more than two standard deviations below the sample baseline
score. Indices of clinically significant change were calculated
on an ITT basis, with missing values derived using multiple
imputation.
Mediation analysis used bootstrap procedures to test the
magnitude of any indirect effects. This method compensates
for the lack of power associated with small samples by re-
sampling data (Preacher & Hayes, 2008). Only data from trial
completers were used as investigations of mechanism require
participants to have received an adequate dose of the treat-
ment. Confidence intervals for indirect effects were calculated
using 5000 resamples (with replacement). Pretreatment CPSS
and mediator scores were accounted for in each analysis. Two
mediation strategies were utilized. First, to examine the
replicability of the mediation effect shown for CT-PTSD previ-
ously (Smith et al., 2007), the ability of change in putative
mediator variables across treatment to mediate the relation-
ship between allocation and change in CPSS scores across
treatment was investigated. Second, to adhere to the require-
ment that the mediator temporally precedes the outcome and
reflect a change occurring during treatment (Kraemer, Wilson,
Fairburn, & Agras, 2002), the ability of pre–mid treatment
changes in putative mediator variables to mediate the rela-
tionship between allocation and posttreatment CPSS was
examined.
Results
Sample and participant flow
Demographic information for N = 29 participants
who entered the study is presented in Table 1.
Figure 1 presents the CONSORT diagram illustrat-
ing participant flow. Between 1st April 2011 and
31st August 2013, 132 young people were referred to
the study. Of these, 63 were not further assessed
after initial telephone screening [sought treatment
for another condition (n = 18), trauma too long ago
(n = 16), unable to contact (n = 7), other primary
diagnosis (n = 5), ongoing threat (n = 4), too old/
young (n = 3), multiple trauma (n = 3), not interested
(n = 3), already in treatment (n = 3) and ongoing
legal action (n = 1)]. There were no age or sex
differences between youth who were assessed and
youth who were excluded at this initial screening
(p > .55). Of 69 cases assessed for suitability, 29
entered the trial (reasons for nonentry detailed in
Figure 1); the majority were community referrals
(n = 19), the remainder ED attendees who were
followed up post-trauma (n = 10). Youth who met
inclusion criteria but declined to participate in the
trial (n = 12) did not differ significantly from trial
participants with respect to age, sex or CPSS score
(M = 24.56, SD = 6.98; p > .1). Fourteen partici-
pants were allocated to CT-PTSD, 15 to WL. The
mean number of therapy sessions in the CT-PTSD
arm was 8.3 (SD = 2.2). One CT-PTSD participant
© 2016 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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did not complete the midtreatment questionnaires
(opting to start medication treatment for depression
and to halt PTSD treatment); the same CT-PTSD
participant and two from the WL arm dropped out
before completing the posttreatment assessment
(one participant did not give a reason for withdrawal;
the other felt that trial participation was no longer
necessary). No participants allocated to WL reported
starting psychological therapy or psychoactive med-
ication.
Pretreatment CT-PTSD/WL comparisons
At trial entry, the CT-PTSD and WL groups were
matched on all stratification variables (Tables 1 and
2), salient demographic and trauma characteristics
and other measures of psychopathology, excepting
ethnicity (where CT-PTSD participants were signifi-
cantly less likely to belong to a minority ethnic
group).
Primary outcome: child-report PTSD-AA at
posttreatment
The ITT analysis of child-reported PTSD-AA at post-
treatment showed a significant between-groups dif-
ference using both the WCS procedure [v2 = 5.81,
df = 1, p < .02, 95% CI for difference .04–.71;
assumes 10/14 (71%) diagnosis free for CT-PTSD
vs. 4/15 (27%) for WL] and the LOCF procedure
[v2 = 10.08, df = 1, p < .002, 95% CI for difference
.18–.80; assumes 10/14 (71%) diagnosis free for CT-
PTSD vs. 2/15 (13%) for WL] to account for
dropouts.
Completer analyses also showed that CT-PTSD
participants were significantly more likely to be free
of PTSD-AA than WL [10/13 (77%) vs. 2/13 (15%)
diagnosis free; v2 = 9.90, df = 1, p = .002; 95% CI for
difference .18–.83] at posttreatment.
Similar results in favour of CT-PTSD emerged
using ICD-10 PTSD as the outcome: ITT analysis
using both WCS [v2 = 7.74, df = 1, p < .006, 95% CI
Table 1 Sample description at randomization
Total sample (n = 29) WL (n = 15) CT-PTSD (n = 14)
Group effectMean/Freq. SD/% Mean/Freq. SD/% Mean/Freq. SD/%
Female 21 72.4 12 80.0 9 64.3 v2 = .90, p = .34
Age 13.3 2.5 12.5 2.6 14.2 2.3 t = 1.89, p = .07
Ethnicity
White British 25 86.2 11 73.3 14 100.0 v2 = 4.33, p < .04
Minority ethnicity 4 13.8 4 26.7 0 0.0
Household income (per annum)
<£20,000 12 46.2a 9 60.0 3 27.3a v2 = 2.74, p = .10
>£20,000 14 53.8a 6 40.0 8 72.7a
IQ 96.0 14.7 96.1 17.3 95.9 12.0 t = .05, p = .96
Any prior trauma 11 37.9 4 26.7 7 50.0 v2 = 1.68, p = .20
Prior mental health problems 9 31.0 5 33.3 4 28.6 Fisher’s exact test, p = .68
Prior mental health treatment 4 13.8 3 20.0 1 7.1 Fisher’s exact test, p = 1.00
Referral source
ED screening 10 34.5 4 26.7 6 42.9 v2 = 5.21, p = .52
Mental health service 8 27.6 5 33.3 3 21.4
General practitioner 4 13.8 2 13.3 2 14.3
Hospital 1 3.4 1 6.7 0 0.0
Children’s services 2 6.9 2 13.3 0 0.0
School nurse 3 10.3 1 6.7 2 14.3
Self-referral 1 3.4 0 0.0 1 7.1
Trauma type
Motor vehicle collision 15 51.7 7 46.7 8 57.1 v2 = 4.51, p = .48
Assault 7 24.1 3 20.0 4 28.6
Medical emergency 1 3.4 1 6.7 0 0.0
House fire 1 3.4 1 6.7 0 0.0
Other 5 17.2 3 20.0 2 14.3
Days since trauma 116.7 38.6 125.5 30.3 107.3 45.1 t = 1.28, p = .21
Ongoing injury at assessment 9 31.0 4 26.7 5 35.7 v2 = .44, p = .51
Attended ED 18 62.1 9 60.0 9 64.3 v2 = .06, p = .81
Ongoing legal/police issues? 16 55.2 9 60.0 7 50.0 v2 = .29, p = .59
PTSD-AA 29 100.0 15 100.0 14 100.0 n/a
ICD-10 PTSD 29 100.0 15 100.0 14 100.0 n/a
DSM-IV PTSD 22 75.9 12 80.0 10 71.4 Fisher’s exact test, p = .68
Any comorbid disorder
Anxiety 25 86.2 13 86.7 12 85.7 Fisher’s exact test, p = 1.00
Affective 16 55.2 7 46.7 9 64.3 Fisher’s exact test, p = .46
Behavioural 15 51.7 7 46.7 8 57.1 Fisher’s exact test, p = .72
ED, emergency department; PTSD-AA, PTSD-alternative algorithm; IQ, intelligence quotient; WL, waiting list.
aThree missing.
© 2016 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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for difference .10–.75; assumes 10/14 (71%) for CT-
PTSD vs. 3/15 (20%) for WL diagnosis free] and
LOCF [v2 = 12.90, df = 1, p < .0001, 95% CI for
difference .25–.85; assumes 10/14 (71%) vs. 1/15
(20%) diagnosis free], as well as completer-only
analysis [v2 = 12.76, df = 1, p < .0001, 95% CI for
difference .32–.85; 10/13 (77%) vs. 1/13 (8%) diag-
nosis free].
Secondary outcomes: PTSD symptoms and severity
For ITT analyses, the CT-PTSD group scored signif-
icantly lower than the WL group on symptom counts
(CPTSDI; mean difference 7.39, 95% CI 4.41–10.37;
p < .0001) and PTSD severity (CPSS; mean difference
17.69, 95% CI 8.62–26.76; p < .0005). Results for
completer analyses were consistent with ITT results
(Table 2).
Secondary outcomes: Clinically significant change
analyses
Significantly more cases showed a clinically signifi-
cant change for PTSD severity in the CT-PTSD
condition than WL [CPSS scores; 11/14 (78.6%) vs.
5/15 (33.3%); Fisher’s exact test, p < .03].
Assessed for eligibility
(n = 69)
Enrolment
Random allocation (n = 29)
Excluded (n = 40)
Refused to participate (n = 12)
Could not be contacted (n = 2)
Did not meet study criteria (n = 26)
No PTSD (19)
Not single trauma (1)
PTSD not primary diag. (2)
Safety/risk issues (2)
Already in treatment (2)
Allocation
Follow-Up 
(11 weeks)
Allocated to CT-PTSD (n = 14)
Completers (n = 13)
Drop out (n = 1)
Follow-Up 
(6 months post-CT-PTSD)
Allocated to WL (n = 15)
Completers (n = 13)
Drop out (n = 2)
Follow-Up 
(12 months post-CT-PTSD)
Completed 11 week follow up
Completers (n = 13)
Completed 11 week follow up
Completers (n = 13)
Analysis
Completed 6 m post-CT-PTSD
follow up
Completers (n = 13)
Completed 12 m post-CT-PTSD
follow up
Completers (n = 13)
Analysed (n = 14) Analysed (n = 15)
Mid CT-PTSD/WL
(5 weeks)
Completed 5 week assessment
Completers (n = 13)
Completed 5 week assessment
Completers (n = 15)
Figure 1 Participant progress (CONSORT flowchart)
© 2016 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
628 Richard Meiser-Stedman et al. J Child Psychol Psychiatr 2017; 58(5): 623–33
Secondary outcomes: other psychopathology and
functioning
At posttreatment, the CT-PTSD group had signifi-
cantly better functioning (CGAS; mean difference
21.01, 95% CI 9.72–32.29; p < .0008), depression
(MFQ; mean difference 14.63, 95% CI .59–28.67;
p < .05), anxiety (SCAS; mean difference 19.15, 95%
CI 5.72–32.57; p < .007), and parent-reported emo-
tional difficulties (SDQ; mean difference 2.77, 95%
CI .60–4.93; p < .02), conduct problems (SDQ; mean
difference 1.73, 95% CI .28–3.18; p < .03) and
hyperactivity (SDQ; mean difference 3.27, 95% CI
1.58–4.94; p < .0005) relative to WL. Results for
completer analyses were consistent with ITT results
(Table 2).
Treatment credibility and therapeutic alliance
Across all assessments CT-PTSD participants con-
dition rated their treatment as highly credible (i.e.
first treatment session, midtreatment and posttreat-
ment; range 36.1–38.3, possible range 4–40) and
their therapeutic alliance as strong (TASC-r scores:
range 43.1–43.7, possible range 12–48).
Six- and 12-month follow-up assessments
Of 13 CT-PTSD cases re-assessed at 6MFU and
12MFU, only one continued to meet criteria for
PTSD-AA; using the WCS procedure, 12/14 (86%)
of all CT-PTSD cases were diagnosis free at follow-
up. According to repeated-measures ANOVAs for
completers, this group also remained improved on
continuous measures of PTSD, depression and anx-
iety at 6MFU and 12MFU assessments (F > 16.71,
p < .002), compared to pretreatment (Table 2).
Effect sizes
Between-group (CT-PTSD vs. WL at posttreatment)
and within-subjects (pre–post) effect sizes are pre-
sented in Table 3. Mean scores for ITT are presented
in Table S1, available online. On an ITT basis, the
CT-PTSD group consistently showed large effect
sizes for improvements relative to pretreatment
Table 2 Outcome measures for completers at each assessment
Outcome variable
WL CT-PTSD
Group effectaM SD n M SD n
PTSD symptoms (CPTSDI)
Pre 11.7 2.9 15 11.9 3.2 14 F(1,28) = .01, p = .92
Post 10.2 4.3 13 2.6 3.6 13 F(1,25) = 28.90, p < .0001
6MFU 1.5 2.6 13
12MFU 2.1 3.6 13
PTSD severity (CPSS)
Pre 30.1 11.5 15 31.1 7.9 14 F(1,28) = .08, p = .78
Post 24.3 16.0 13 6.2 10.5 13 F(1,25) = 16.36, p < .0006
6MFU 5.2 8.6 13
12MFU 5.5 6.2 13
Depression (MFQ)
Pre 27.8 16.6 15 29.3 11.6 14 F(1,28) = .08, p = .78
Post 25.0 21.5 13 11.2 14.0 13 F(1,25) = 4.66, p < .04
6MFU 11.3 10.9 13
12MFU 8.2 7.2 13
Anxiety (SCAS)
Pre 54.0 25.8 15 45.6 18.4 14 F(1,28) = 1.01, p = .32
Post 49.5 34.5 13 19.5 18.0 13 F(1,25) = 7.50, p < .02
6MFU 16.2 15.4 13
12MFU 14.2 10.1 13
Functioning (CGAS)
Pre 58.5 10.5 15 57.3 8.6 14 F(1,28) = .12, p = .73
Post 55.2 13.8 13 77.4 14.2 13 F(1,25) = 17.44, p < .0004
Emotional difficulties (SDQ)
Pre 6.3 3.3 15 5.8 2.4 13 F(1,27) = .23, p = .64
Post 5.6 3.5 11 3.3 2.1 13 F(1,22) = 8.53, p < .01
Conduct problems (SDQ)
Pre 4.2 2.3 15 2.9 2.0 13 F(1,27) = 2.43, p = .13
Post 4.4 2.8 11 1.8 1.6 11 F(1,22) = 6.26, p < .03
Hyperactivity (SDQ)
Pre 6.3 2.8 15 5.4 3.1 13 F(1,27) = .64, p = .43
Post 6.2 2.4 11 3.2 2.2 12 F(1,22) = 18.28, p < .0004
Pre = pretreatment (i.e. at randomization); Post = post-CT-PTSD/WL (Week 11); 6MFU = 6-month follow-up; 12MFU = 12-month
follow-up; CPSS, Child PTSD Symptom Scale; CT-PTSD, Cognitive Therapy for PTSD; SDQ, Strengths and Difficulties Question-
naire; WL, waiting list.
aAt pretreatment, one-way ANOVA; at posttreatment, one-way ANCOVA (pretreatment scores as covariates).
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scores and the WL group at posttreatment on all
outcomes. For ITT analyses the WL group also
experienced small to medium effect size improve-
ments for PTSD symptomatology, but small or no
improvement on other indices.
Mediation analysis
Pre-, mid- and posttreatment data on putative medi-
ator variables, with between-group comparisons, are
displayed in Table S2; the WL group scored signifi-
cantly higher than the CT-PTSD group on each
variable at posttreatment (all p < .03). Correlations
between pre–post changes in CPSS scores and pre–
post changes in potential mediators were large and
significant for trauma-related appraisals, memory
quality, trauma-related rumination and safety-
seeking behaviours [rs(26) = .48–67, p < .02], but not
self-blame or social support (MSPSS; r = .10 for
each variable, p > .63). These latter variables were,
therefore, not considered further.
Our first mediation strategy addressed whether the
relationship between allocation and pre–post change
in PTSD symptomatology was mediated by pre–post
change in our putative mediators (see Figure S1a for
pathways, TableS3 for coefficients). Pre–post changes
in trauma-related misappraisals, memory quality,
rumination and safety-seeking behaviours were sig-
nificant mediators of the relationship between treat-
ment allocation and pre–post change in CPSS scores.
The second mediation strategy considered whether
pre–mid changes in our putative mediator variables
mediated the relationship between allocation and
CPSS scores at posttreatment (see Figure S1b for
pathways and Table S3 for coefficients). According to
this method, trauma-related misappraisals and
safety-seeking behaviours, but not memory quality
or rumination, were significant mediators.
Discussion
Consistent with our hypotheses, this RCT provided
preliminary support for the efficacy of CT-PTSD as a
treatment for youth with PTSD in the first 2- to 6-
months post-trauma. Relative to a WL, at posttreat-
ment CT-PTSD led to greater loss of an age-appro-
priate PTSD diagnosis (and of an ICD-10 diagnosis)
and reduced PTSD symptoms, as well as significant
improvements in depression, anxiety, clinician-rated
functioning and other comorbidity. There was also
good preliminary support for the role of psycho-
logical mechanisms in mediating the relationship
between allocation and outcome, consistent with the
stated targets of CT-PTSD (Smith et al., 2010). This
is the first study to show the efficacy of a psycholog-
ical treatment over natural recovery for the early
treatment of PTSD in youth and the first study to
show the efficacy of any treatment for PTSD in youth
in the early post-trauma window of 2–6 months.
Effect sizes for CT-PTSD in this trial are compara-
ble to the earlier evaluations of CT-PTSD for youth
with chronic PTSD (Smith et al., 2007), CT-PTSD as
an early treatment for adult PTSD (Ehlers et al.,
2003) and trauma-focused cognitive-behavioural
therapy for multiple-trauma PTSD such as child
sexual abuse (Cohen et al., 2004). CT-PTSD was also
Table 3 Effect sizes on outcome measures for intent-to-treat and completer analyses
Post-treatment Follow-up
WL
(pre to
post)a
CT-PTSD
(pre to
post)a
CT-PTSD
vs.
WL (post)b
CT-PTSD
(pre to
6MFU)a
CT-PTSD
(pre to
12MFU)a
Intent-to-treat
PTSD symptoms (CPTSDI) .48 2.78 2.01 3.55 2.86
PTSD severity (CPSS) .53 2.65 1.23 3.21 3.63
Depression (MFQ) .11 1.43 .84 1.59 2.17
Anxiety (SCAS) .25 1.40 1.56 1.70 2.09
Functioning (CGAS) .23 1.73 1.58
Emotional problems (SDQ) .07 1.20 1.02
Conduct problems (SDQ) .07 .56 1.20
Hyperactivity (SDQ) .09 .92 1.51
Completer
PTSD symptoms (CPTSDI) .43 2.71 1.91 3.54 2.85
PTSD severity (CPSS) .41 2.68 1.34 3.15 3.63
Depression (MFQ) .14 1.41 .77 1.60 2.20
Anxiety (SCAS) .15 1.43 1.09 1.74 2.12
Functioning (CGAS) .27 1.71 1.58
Emotional problems (SDQ) .21 1.11 .82
Conduct problems (SDQ) .06 .61 1.12
Hyperactivity (SDQ) .03 .77 1.26
Pre = pretreatment (i.e. at randomization); Post = post-CT-PTSD/WL (Week 11); 6MFU = 6-month follow-up; 12MFU = 12-month
follow-up; CPSS, Child PTSD Symptom Scale; CT-PTSD, Cognitive Therapy for PTSD; SDQ, Strengths and Difficulties Question-
naire; WL, waiting list.
aWithin-group; negative scores indicate worsening symptomatology/functioning.
bBetween-group; positive scores indicate superiority of CT-PTSD.
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very acceptable to trial participants, with only one
drop out and high ratings for treatment credibility
and therapist alliance. In summary, these data
suggest CT-PTSD is a potentially powerful and
acceptable early treatment for youth with PTSD that
may yield sustained improvements and benefit
broader mental health and functioning.
Youth in the WL arm experienced some nontrivial
recovery (33% experienced clinically significant
change), at a level broadly comparable with other WL-
controlled RCTs (Goldbeck, Muche, Sachser, Tutus, &
Rosner, 2016; King et al., 2000; Smith et al., 2007).
Nevertheless, this RCT suggests that youth identified
as having PTSD in the 2- to 6-months window post-
trauma are more likely than not to require treatment.
This was particularly apparent when considering
functioning and depression data, which showed con-
siderable improvement in the CT-PTSD arm but no
changeinWL.Giventhescaleofthe issueandtheriskof
long-term poor functioning, clearly more research is
neededconcerninghowtreatment inthiswindowmight
be deliveredmore cost-effectively.
This study provides support for the role of cognitive
mechanisms in treatment responsiveness. The media-
tion effect for misappraisals replicated a previous find-
ing with chronic PTSD youth (Smith et al., 2007). This
studyaddstopreviousfindingsbypreliminarilydemon-
strating the effect of thesemechanisms relative to other
plausible but nontheory-derived mechanisms, extend-
ing the range of cognitive mechanisms considered
(memory characteristics, rumination and safety-seek-
ing behaviours) and utilizing a more robust mediation
analysis procedure. When using this procedure, only
misappraisalsandsafety-seekingbehaviours showeda
mediation effect. Thesedataprovideadditional support
for the utility of a cognitivemodel of PTSD in youth and
suggest further research into these mechanisms is
warranted; such mechanisms may be possible treat-
ment targets for more easily disseminated treatments
(e.g. computerized or self-help therapy packages).
This trial has several limitations. While in line with
our prestudy power calculation and adequately
powered to reveal significant treatment effects of
CT-PTSD, the limited sample size rendered the study
susceptible to bias (e.g. the unbalanced ethnicity, a
trend towards unbalanced socioeconomic character-
istics). It is unclear whether the limited representa-
tion of males in the trial sample (only 27%) also
reflects this issue, or results from problems engaging
with this group. The generalizability of the study
findings is limited by the use of well-supervised
clinical psychologists who were very familiar with a
cognitive understanding of PTSD in youth. Some of
the measures used to assess mediation effects did
not have good internal consistency in this sample.
While the WL arm may reflect a ‘watchful waiting’
approach, it is unclear how well the WL arm reflects
‘natural recovery’ (as participants knew they would
receive treatment soon). Treatment fidelity was not
formally assessed using a sessional coding system.
Future evaluations of CT-PTSD, for acute or
chronic PTSD, now need to consider its utility
relative to an ‘active’ control condition including
therapist contact (e.g. supportive counselling), and
consider its role as part of stepped-care and
indicated interventions for trauma-exposed youth
that may be more cost-effective. Careful attention
to recruitment and engagement issues will be
required for any future evaluation of CT-PTSD as
an early treatment. Despite recruiting from a wide
area (the counties of Cambridgeshire, Norfolk,
Suffolk, Essex, Bedfordshire and Hertfordshire in
England, comprising several hundred thousand
youth in the target age range) and having
29 months to recruit, recruitment rate was slow.
While research into potential barriers to seeking or
accessing care is needed (e.g. parental understand-
ing, more widespread use of screening tools, refer-
ral pathways), these data may alert clinicians and
referrers to the possibility of successful early
treatment for PTSD that results from commonly
occurring traumatic stressors.
Supporting information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Putative mediation pathways.
Table S1. Scores on outcome measures at posttreat-
ment and follow-up based on multiple imputation.
Table S2. Mediator measures for completers at each
assessment.
Table S3. Mediators of treatment responsiveness.
Appendix S1. CONSORT 2010 checklist of information
to include when reporting a randomized trial.
Acknowledgements
The trial was funded by a Medical Research Council
(MRC) Clinician Scientist Fellowship awarded to the
first author (G0802821). P.S. and D.M.C. co-authored
the therapy manual used in this trial and
receive royalties from this publication. The remaining
authors have no competing or potential conflicts of
interests.
The authors gratefully acknowledge the support of
the assessors (Sarah-Jane Archibald, Theresa Dahm,
Emma Hill, Caitlin Hitchcock, Cari-Lene Mul, Fionnu-
ala Murphy, Jill Newby, Susanne Schweizer, Lysandra
Sinclaire-Harding), Trial Steering Committee [William
Yule (chair), Samantha Cartwright-Hatton and Paul
Stallard], lay advisors, the National Institute of Health
Research Clinical Research Network (NIHR CRN) and all
referrers and participants.
Correspondence
Richard Meiser-Stedman, Department of Clinical Psy-
chology, University of East Anglia, Norwich, NR4 7TJ,
UK; Email: r.meiser-stedman@uea.ac.uk
© 2016 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
doi:10.1111/jcpp.12673 Cognitive Therapy as early treatment for PTSD 631
Key points
• Early interventions for trauma-exposed youth to date have focused on the prevention of PTSD in the first few
weeks following a trauma with limited success.
• A multiple-session individual psychological treatment, Cognitive Therapy for PTSD (CT-PTSD), delivered in the
first 2- to 6-month post-trauma, was efficacious relative to a wait list (WL) control arm.
• Recovery in the WL arm was limited (particularly in terms of depression and functioning), suggesting that
further monitoring in this period is not warranted.
• Mediation analysis suggested that CT-PTSD works through reducing trauma-related misappraisals and safety-
seeking behaviours.
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